Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 17, 2013
EMD Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany, today announced that its Biodevelopment Centre in Martillac, France, has been recertified by the French National Agency for Medicines and Health Products Safety (ANSM), the ...
read more
Monday, February 27, 2012
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, today announced it will be partnering with Charles River Laboratories International, Inc. of Wilmington, MA, to exclusively license EMD Millipore's TrueSpike™ technology. ...
read more
Wednesday, March 11, 2015
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, today announced that it will hold its first virtual conference for 2015, "Headache-Free Pharma QC," on April 1 and 2, 2015.
read more
Monday, February 25, 2019
WuXi Biologics announced that the EMA has completed the PAI of the company's cGMP Drug Substance and Drug Product manufacturing facilities for the production of Trogarzo with no critical findings.
read more
Tuesday, February 01, 2022
Elusys Therapeutics has finalized a contract with the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS) for the continued supply of ANTHIM (obiltoxaximab), an anthrax ...
read more
ELPRO has updated its liberoMANAGER database service for collecting and analyzing temperature records created during shipment or storage of temperature sensitive goods.
read more
Thursday, October 14, 2021
Element Materials Technology (Element) has acquired Nanosyn, a full-service pharmaceuticals contract development and manufacturing organization, significantly strengthening Element’s offering for pharmaceutical and biopharmaceutical customers in ...
read more
The EIB and BioNTech SE concluded a €100 million debt financing agreement to support the development of the company’s COVID-19 vaccine program.
read more
Metro Charlotte-based, Ei, A Pharmaceutical SolutionWorks? announced that it now has minoxidil in a convenient sprayer version available for private label and branded customers. Minoxidil, which was first used as an oral drug to treat high blood ...
read more
EAG Laboratories has announced the launch of a new laboratory in China dedicated to improving materials, products and electronics. Built in Shanghai, this facility brings the advanced imaging and surface analysis expertise and technology to China, ...
read more
Dyadic International, Inc. a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of ...
read more
PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, today announced the award of a US$3.3 million contract from the US Defense Threat Reduction Agency (DTRA) to develop biodefence vaccine adjuvants using the company’s ...
read more
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE/Euronext: DSM KON), today announced the signing of a 3 year master supply agreement with Eisai Inc., based in Woodcliff Lake, NJ,...
read more
DSM, a global leader in materials science and regenerative medicine, announced today the launch of its cellular therapy development services. Cellular therapies use a patient’s own cells to improve healing of an injury or disease. DSM develops ...
read more
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM announced today that their new cGMP custom biopharmaceutical manufacturing 'biologics plant of the future' will open in June 2013.
read more